Filing Details
- Accession Number:
- 0001209191-21-055507
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-10 17:27:14
- Reporting Period:
- 2021-08-02
- Accepted Time:
- 2021-09-10 17:27:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-02 | 15 | $3.34 | 5,768,844 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-03 | 15 | $3.17 | 5,768,859 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-04 | 15 | $3.18 | 5,768,874 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-05 | 15 | $3.11 | 5,768,889 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-06 | 15 | $3.01 | 5,768,904 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-09 | 15 | $2.93 | 5,768,919 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-10 | 15 | $2.96 | 5,768,934 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-11 | 15 | $2.98 | 5,768,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-13 | 15 | $2.92 | 5,768,964 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-16 | 15 | $2.92 | 5,768,979 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-17 | 15 | $3.05 | 5,768,994 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-18 | 15 | $2.97 | 5,769,009 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-19 | 15 | $3.02 | 5,769,024 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-20 | 15 | $2.96 | 5,769,039 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-23 | 15 | $2.87 | 5,769,054 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-24 | 15 | $2.89 | 5,769,069 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-25 | 15 | $2.79 | 5,769,084 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-26 | 15 | $2.82 | 5,769,099 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-27 | 15 | $2.84 | 5,769,114 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-30 | 15 | $2.88 | 5,769,129 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-08-31 | 15 | $2.93 | 5,769,144 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
